Nome | Settore | Analyst Name | Analyst Job Title | Rating Quantitativo | Data | |
---|---|---|---|---|---|---|
IQVIA Holdings Inc | Salute | Rachel Elfman | Equity Analyst | 07/05/2025 | ||
Novo Nordisk AS ADR | Salute | Karen Andersen | Director | 07/05/2025 | ||
Novo Nordisk AS Class B | Salute | Karen Andersen | Director | 07/05/2025 | ||
LivaNova PLC | Salute | Debbie Wang | Senior Equity Analyst | 07/05/2025 | ||
Sartorius AG | Salute | Max Jousma | Equity Analyst | 07/05/2025 | ||
Sartorius AG Vorz-Inhaber-Akt ohne Stimmrecht | Salute | Max Jousma | Equity Analyst | 07/05/2025 | ||
Sartorius Stedim Biotech SA | Salute | Max Jousma | Equity Analyst | 07/05/2025 | ||
Fresenius SE & Co KGaA | Salute | Max Jousma | Equity Analyst | 07/05/2025 | ||
Diasorin SpA | Salute | Max Jousma | Equity Analyst | 07/05/2025 | ||
Coloplast AS ADR | Salute | Debbie Wang | Senior Equity Analyst | 07/05/2025 | ||
Coloplast AS Class B | Salute | Debbie Wang | Senior Equity Analyst | 07/05/2025 | ||
Evotec SE | Salute | Rachel Elfman | Equity Analyst | 07/05/2025 | ||
Evotec SE ADR | Salute | Rachel Elfman | Equity Analyst | 07/05/2025 | ||
Zoetis Inc Class A | Salute | Debbie Wang | Senior Equity Analyst | 07/05/2025 | ||
Vertex Pharmaceuticals Inc | Salute | Rachel Elfman | Equity Analyst | 06/05/2025 | ||
Align Technology Inc | Salute | Keonhee Kim | Equity Analyst | 06/05/2025 | ||
Demant AS | Salute | Max Jousma | Equity Analyst | 06/05/2025 | ||
Waters Corp | Salute | Julie Utterback | Senior Equity Analyst | 06/05/2025 | ||
Fresenius Medical Care AG | Salute | Julie Utterback | Senior Equity Analyst | 06/05/2025 | ||
Fresenius Medical Care AG ADR | Salute | Julie Utterback | Senior Equity Analyst | 06/05/2025 |